Danaher Corporation $DHR is Sei Investments Co.'s 6th Largest Position

Key Points

• Sei Investments Co. increased its stake in Danaher Corporation by 0.9%, acquiring an additional 8,924 shares and owning a total of 1,026,281 shares, valued at approximately $233.7 million.
• Danaher reported earnings of $1.80 per share for the most recent quarter, beating analysts' expectations, with quarterly revenue of $5.94 billion.
• Analysts have a generally bullish outlook on Danaher, with a consensus rating of "Moderate Buy" and an average price target of $247.61 per share.

Sei Investments Co. increased its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 0.9% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 1,026,281 shares of the conglomerate's stock after purchasing an additional 8,924 shares during the period. Danaher makes up approximately 2.2% of Sei Investments Co.'s investment portfolio, making the stock its 6th largest position. Sei Investments Co. owned 0.14% of Danaher worth $233,655,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Heck Capital Advisors LLC purchased a new stake in shares of Danaher during the 4th quarter worth $27,000. GHP Investment Advisors Inc. lifted its position in shares of Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after purchasing an additional 99 shares during the last quarter. Sierra Ocean LLC lifted its position in shares of Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after purchasing an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC purchased a new stake in shares of Danaher during the 1st quarter worth $31,000. Finally, Dunhill Financial LLC lifted its position in shares of Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after purchasing an additional 67 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Stock Up 1.5%

Shares of NYSE DHR traded up $3.2250 during trading on Tuesday, reaching $212.2350. The company had a trading volume of 1,974,964 shares, compared to its average volume of 4,221,165. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $279.90. The stock has a market cap of $151.97 billion, a PE ratio of 45.14, a P/E/G ratio of 2.94 and a beta of 0.73. The business's 50-day moving average is $200.14 and its 200 day moving average is $199.45.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company had revenue of $5.94 billion for the quarter, compared to analysts' expectations of $5.83 billion. During the same period last year, the firm posted $1.72 earnings per share. Danaher's revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages recently commented on DHR. Jefferies Financial Group cut their price target on shares of Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a research note on Tuesday, April 22nd. The Goldman Sachs Group cut their price target on shares of Danaher from $260.00 to $240.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 23rd. UBS Group cut their price target on shares of Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a research note on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft cut their price target on shares of Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Finally, Wells Fargo & Company cut their price target on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a research note on Wednesday, July 23rd. Seventeen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $247.61.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.